RxDoctor Payments Data

S Christopher Frontario, DO

Vascular Surgery · Stratford, NJNPI 1427407204

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $9,627 of the $11,597 with a category attached, or 83.0%. 30 manufacturers reported payments, led by Medtronic at 28.4% of the total.

$11,597in general payments, 2019–2025

Across 183 payments — averaging $63.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • W. L. Gore & Associates, Inc.$2K
  • Inari Medical, Inc.$790
  • Cook Medical LLC$765
  • Silk Road Medical, Inc.$657
  • Stryker$538
  • plus $3K from 24 others

What the payments were for

  • Travel & lodging$1,44712%
  • Food & beverage$9,62783%
  • Education$5235%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,597 in reported general payments places this provider in the 70th percentile of 182 vascular surgery providers in New Jersey.

See all vascular surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$142,315
Medicare patients
603
Services billed
1,639

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban59$44,606
EliquisApixaban11$7,564

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Stratford

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →